Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-volume oral picosulfate + magnesium citrate vs standard 4-liter PEG for bowel preparation
KCT0000470Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of sodium picosulfate, magnesium, macrogol, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jul 2012; status: completed.
02
Drugs
sodium picosulfatemagnesiummacrogol
Beyond the preview
Go deeper on KCT0000470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000470.